See the notice on TED website
1. Beschaffer
1.1.
Beschaffer
Offizielle Bezeichnung: NHS National Services Scotland (NSS)
Rechtsform des Erwerbers: Einrichtung des öffentlichen Rechts
Tätigkeit des öffentlichen Auftraggebers: Gesundheit
1.1.
Beschaffer
Offizielle Bezeichnung: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
Rechtsform des Erwerbers: Einrichtung des öffentlichen Rechts
Tätigkeit des öffentlichen Auftraggebers: Gesundheit
1.1.
Beschaffer
Offizielle Bezeichnung: Region Hovedstaden (REGIONH)
Rechtsform des Erwerbers: Einrichtung des öffentlichen Rechts
Tätigkeit des öffentlichen Auftraggebers: Gesundheit
1.1.
Beschaffer
Offizielle Bezeichnung: Fundacja Klaster Lifescience Krakow (KLSK)
Rechtsform des Erwerbers: Einrichtung des öffentlichen Rechts
Tätigkeit des öffentlichen Auftraggebers: Gesundheit
1.1.
Beschaffer
Offizielle Bezeichnung: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)
Rechtsform des Erwerbers: Einrichtung des öffentlichen Rechts
Tätigkeit des öffentlichen Auftraggebers: Gesundheit
2. Verfahren
2.1.
Verfahren
Titel: PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.
Beschreibung: This PIN provides early information about the expected starting date and purchase volume and about the open market consultation that is organised in preparation of this precommercial procurement (PCP). The procurement aims to trigger new solutions to be developed and tested to address the following challenge: REHEAL aims to stimulate the development of new solutions that will support the transition of healthcare supply chains from linear to circular models to enhance sustainability and resilience. Key areas include developing supply chain management platforms that prioritise product longevity, material tracking, and regulatory compliance, employing advanced data analytics and AI to optimise reverse logistics and explore recovery opportunities. Solutions should enable scenario analysis and modelling, allowing healthcare providers to identify and implement the most impactful strategies tailored to regional needs.
2.1.1.
Zweck
Art des Auftrags: Dienstleistungen
Haupteinstufung (cpv): 73100000 Dienstleistungen im Bereich Forschung und experimentelle Entwicklung
Zusätzliche Einstufung (cpv): 73110000 Forschungsdienste, 72212445 Entwicklung von Software für das Kundenbeziehungsmanagement (CRM), 72222300 Informationstechnologiedienste, 90713000 Beratung in Umweltfragen, 90714100 Umweltinformationssysteme, 90711300 Analyse von Umweltindikatoren in anderen Bereichen als dem Bausektor, 80500000 Ausbildung, 79342200 Reklamedienste, 90711000 Umweltfolgenabschätzung in anderen Bereichen als dem Bausektor, 72212783 Entwicklung von Inhaltsverwaltungssoftware, 85100000 Dienstleistungen des Gesundheitswesens
2.1.2.
Erfüllungsort
Stadt: Edinburgh
Postleitzahl: EH12 9EB
Land: Vereinigtes Königreich
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Erfüllungsort
Stadt: Lugo
Land, Gliederung (NUTS): Lugo (ES112)
Land: Spanien
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Erfüllungsort
Stadt: Copenhagen
Land, Gliederung (NUTS): Københavns omegn (DK012)
Land: Dänemark
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Erfüllungsort
Stadt: Kraków
Land, Gliederung (NUTS): Miasto Kraków (PL213)
Land: Polen
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Erfüllungsort
Stadt: Attiki
Land, Gliederung (NUTS): Δυτική Αττική (EL306)
Land: Griechenland
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.3.
Wert
Geschätzter Wert ohne MwSt.: 3 000 000,00 EUR
2.1.4.
Allgemeine Informationen
Zusätzliche Informationen: The research and development (R&D) services will be carried out primarily within the European Union and/or in countries associated with the Horizon Europe Programme. At least 50% of the total value of the R&D activities shall take place within the EU or associated countries. Contractors must ensure that none of the contracted services are performed in countries nor by entities that are subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that none of the goods procured or used for the procurement were developed, produced or supplied in countries or by entities that are subject to such restrictive measures. This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs. Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation. This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure. This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226919 – ReHEAL https://www.rehealhorizon.eu . *The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.* For additional information, please contact: REHEAL Project Coordination Team, Email:pcp@rehealhorizon.eu More information is on the REHEAL website https://www.rehealhorizon.eu.
Rechtsgrundlage:
Andere
3. Teil
3.1.
Teil: PAR-0001
Titel: PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.
Beschreibung: This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (socalled ‘Buyers Group’).The procurement will take the form of a precommercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected R&D provider will be awarded a framework agreement that covers the following R&D phases and a specific contract per phase.Procurement will take the form of a precommercial procurement (PCP), that will allow procurers to buy R&D from several competing suppliers in parallel; to compare alternative solution approaches and to identify the best valueformoney solutions that the market can deliver to address those needs. The PCP will be structured as a fasttrack PCP, specifically designed to accelerate innovation cycles and reduce timetoimpact whilst remaining fully compliant with Horizon Europe PCP principles. In contrast to traditional PCPs that strictly separate prototyping and piloting into distinct phases, REHEAL adopts a fasttrack approach in which prototyping and piloting are combined into a single integrated R&D phase. This approach is justified by the digital, softwareintensive nature of the expected solutions, which enables rapid iteration, continuous testing and early validation in real operational environments. The PCP will be organised into three consecutive phases: Phase 1 – Solution design and feasibility: Selected contractors will elaborate detailed solution designs, technical architectures, and feasibility studies addressing the REHEAL challenge, including risk assessment and validation plans. Phase 2 – Prototyping and piloting (combined phase): Contractors will develop functional prototypes and pilot them directly in operational healthcare environments across the Buyers Group sites. Prototyping and piloting are grouped together to enable rapid learning loops, realworld testing, and early assessment of usability, scalability, sustainability impact, and integration into existing healthcare supply chains. Phase 3 – followup procurement: subject to the successful completion of Phase 2 and availability of funding, the REHEAL Buyers Group may launch a separate followup procurement to deploy and upscale the most promising solution(s). This Phase 3 is not part of the PCP itself, but is foreseen as a potential next step to ensure market uptake and impact, in line with Horizon Europe PCP guidance. After each PCP phase, interim evaluations will be carried out, and the contractors offering the best value for money will be invited to progress to the next phase. Each selected operator will receive a framework contract, with specific contracts awarded per phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed. All interested operators are invited to take part in the upcoming open market consultation (OMC) (regardless of their geographic location, size or governance structure of their organisation). The OMC will be organised as a series of meetings. These meetings will provide you with an overview on the procurement objectives, the PCP process and the main clauses of the contract. You will also have the opportunity to ask questions. A first EUlevel online webinar will be held on 11 February 2026, introducing the project, challenge, requirements, Buyers Group, overall PCP process and timeline, to tools available to support applicants. This will be followed by a series of five live meetings hosted in each of the procurer locations mentioned in under Section I.1) During those meetings, the procurers will offer presentations in their own local languages, namely English, Spanish, Danish, Polish and Greek. These meetings will take place between 16 – 27 February 2026. The meetings will be followed by an EUlevel live event on 4 March and a final EU webinar, on 31 March 2026, in English. Registration for OMC meetings will be available on the REHEAL website https://www.rehealhorizon.eu – from 19 January 2026. The contract notice is expected to be published in July 2026 and the procurement is expected to start in late 2026 and end in late 2028. Testing is expected to take place in Scotland (UK), Galicia (Spain), Region Hovedstaden (Denmark), Krakow (Poland), and Athens (Greece). This testing may also serve as a first customer test reference for the contractors. The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
3.1.1.
Zweck
Art des Auftrags: Dienstleistungen
Haupteinstufung (cpv): 73100000 Dienstleistungen im Bereich Forschung und experimentelle Entwicklung
3.1.2.
Erfüllungsort
Stadt: Edinburgh
Land: Vereinigtes Königreich
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Erfüllungsort
Stadt: Lugo
Land, Gliederung (NUTS): Lugo (ES112)
Land: Spanien
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Erfüllungsort
Stadt: Copenhagen
Land, Gliederung (NUTS): Københavns omegn (DK012)
Land: Dänemark
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Erfüllungsort
Stadt: Kraków
Land, Gliederung (NUTS): Miasto Kraków (PL213)
Land: Polen
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Erfüllungsort
Stadt: Attiki
Land, Gliederung (NUTS): Δυτική Αττική (EL306)
Land: Griechenland
Zusätzliche Informationen: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.3.
Dauer
Andere Laufzeit: Unbekannt
3.1.4.
Wert
Geschätzter Wert ohne MwSt.: 3 000 000,00 EUR
3.1.5.
Allgemeine Informationen
Die Beschaffung fällt unter das Übereinkommen über das öffentliche Beschaffungswesen: nein
Diese Auftragsvergabe ist auch für kleine und mittlere Unternehmen (KMU) geeignet: ja
3.1.9.
Weitere Informationen, Schlichtung und Nachprüfung
Schlichtungsstelle: NHS National Services Scotland (NSS)
Überprüfungsstelle: NHS National Services Scotland (NSS)
Organisation, die weitere Informationen für die Nachprüfungsverfahren bereitstellt: NHS National Services Scotland (NSS)
8. Organisationen
8.1.
ORG-0001
Offizielle Bezeichnung: NHS National Services Scotland (NSS)
Registrierungsnummer: GB 654 851 612
Postanschrift: 1 South Gyle Crescent
Stadt: Edinburgh
Postleitzahl: EH12 9EB
Land: Vereinigtes Königreich
Kontaktperson: REHEAL Coordination Team
Telefon: +44 1312756000
Rollen dieser Organisation:
Beschaffer
Überprüfungsstelle
Organisation, die weitere Informationen für die Nachprüfungsverfahren bereitstellt
Schlichtungsstelle
8.1.
ORG-0002
Offizielle Bezeichnung: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
Registrierungsnummer: Q2729003A
Postanschrift: Doctor Ulises Romero No. 1 – 2a planta
Stadt: Lugo
Postleitzahl: 27003
Land, Gliederung (NUTS): Lugo (ES112)
Land: Spanien
Kontaktperson: REHEAL Coordination Team
Telefon: +34 981580633
Rollen dieser Organisation:
Beschaffer
8.1.
ORG-0003
Offizielle Bezeichnung: Region Hovedstaden (REGIONH)
Registrierungsnummer: 30113721
Postanschrift: Regionsgården – Kongens Vænge 2
Stadt: Hillerød
Postleitzahl: 3400
Land, Gliederung (NUTS): Københavns omegn (DK012)
Land: Dänemark
Kontaktperson: REHEAL Coordination Team
Telefon: +45 21537888
Rollen dieser Organisation:
Beschaffer
8.1.
ORG-0004
Offizielle Bezeichnung: Fundacja Klaster Lifescience Krakow (KLSK)
Registrierungsnummer: 0000458418
Postanschrift: Bobrzyńskiego 14
Stadt: Kraków
Postleitzahl: 30-348
Land, Gliederung (NUTS): Miasto Kraków (PL213)
Land: Polen
Kontaktperson: REHEAL Coordination Team
Telefon: +48 789 490 146
Rollen dieser Organisation:
Beschaffer
8.1.
ORG-0005
Offizielle Bezeichnung: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)
Registrierungsnummer: 000288501000 (GEMI)
Postanschrift: 6, Erythrou Stavrou
Stadt: Marousi, Athens
Postleitzahl: 15123
Land, Gliederung (NUTS): Δυτική Αττική (EL306)
Land: Griechenland
Kontaktperson: REHEAL Coordination Team
Telefon: +30 2117508697
Rollen dieser Organisation:
Beschaffer
8.1.
ORG-0000
Offizielle Bezeichnung: Publications Office of the European Union
Registrierungsnummer: PUBL
Stadt: Luxembourg
Postleitzahl: 2417
Land, Gliederung (NUTS): Luxembourg (LU000)
Land: Luxemburg
Telefon: +352 29291
Rollen dieser Organisation:
TED eSender
Informationen zur Bekanntmachung
Kennung/Fassung der Bekanntmachung: 7bb3386e-bc97-41a2-a449-e938965a8d4c - 01
Formulartyp: Planung
Art der Bekanntmachung: Vorinformation oder eine regelmäßige nicht verbindliche Bekanntmachung nur zu Informationszwecken
Unterart der Bekanntmachung: 4
Datum der Übermittlung der Bekanntmachung: 19/12/2025 11:00:07 (UTC+00:00) Westeuropäische Zeit, GMT
Sprachen, in denen diese Bekanntmachung offiziell verfügbar ist: Englisch
Veröffentlichungsnummer der Bekanntmachung: 850409-2025
ABl. S – Nummer der Ausgabe: 246/2025
Datum der Veröffentlichung: 22/12/2025
Voraussichtliches Datum der Veröffentlichung einer Auftragsbekanntmachung im Rahmen dieses Verfahrens: 16/06/2026